Quote:
Originally Posted by Damien
As pointed out elsewhere the terms of a trade deal would likely seek to make regulation more favourable to American drug and healthcare companies. They won't seek to make the NHS disappear but they will want to protect their interests and maximise profits for the contracts they seek. There are all sorts of things they might push for, most of which I don't really understand to do with how contracts for medicines are made, but a lack of regulation in favour of private business is unlikely to benefit us as taxpayers or patients.
|
Any regulations would be the SAME as for ANY company from ANYWHERE in the world. They would be operating in this country and would therefore be classed as a UK company. It is the EU that goes around insisting on common regulations in order to make everything as expensive as in Germany.